Once-a-day oxycodone formulations
US7846476B2 · kind B2 · utility
64Cited by
89References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2002 |
| Grant date | Dec 7, 2010 |
| Priority date | — |
| Expiry date | Sep 18, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2018
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to sustained release formulations containing oxycodone or a pharmaceutically acceptable salt thereof which provide a mean C24/Cmax oxycodone ratio of 0.6 to 1.0 or 0.7 to 1 after oral administration at steady state to patients and methods thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.